NCT03941327 is a NA clinical trial of AxoGuard Nerve Cuff in Spinal Accessory Nerve Injury, sponsored by University of Mississippi Medical Center.

Who is sponsoring NCT03941327?

NCT03941327 is sponsored by University of Mississippi Medical Center.

What drugs are being tested in NCT03941327?

Interventions in NCT03941327: AxoGuard Nerve Cuff.

What condition does NCT03941327 study?

NCT03941327 studies Spinal Accessory Nerve Injury, Cervical Lymphadenopathy.

Is NCT03941327 still recruiting?

NCT03941327 is currently status unknown. Last updated 7 May 2019.

Last reviewed 2019-05-07 · How we verify

NCT03941327

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Do AxoGuard Implants Decrease Shoulder Disability After Neck Dissections

Status unknown NA Last updated 7 May 2019

What this trial tests

NA trial testing AxoGuard Nerve Cuff in Spinal Accessory Nerve Injury in 100 participants. Status unknown.

Timeline

1 May 2019

Primary endpoint
1 May 2020

1 May 2020

Quick facts

Lead sponsor	University of Mississippi Medical Center
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	100
Start date	1 May 2019
Primary completion	1 May 2020
Estimated completion	1 May 2020
Sites	1 location across United States

Drugs / interventions tested

AxoGuard Nerve Cuff

Conditions studied

Spinal Accessory Nerve Injury — all drugs for Spinal Accessory Nerve Injury →
Cervical Lymphadenopathy — all drugs for Cervical Lymphadenopathy →

Sponsor

University of Mississippi Medical Center

Who can join

18 and older, any sex, with Spinal Accessory Nerve Injury or Cervical Lymphadenopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine whether Axoguard nerve protectors have a role in preventing shoulder disability and pain following spinal accessory nerve sparing neck dissections.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Modern Trends for Peripheral Nerve Repair and Regeneration: Beyond the Hollow Nerve Guidance Conduit.
Carvalho CR, Oliveira JM, Reis RL. · · 2019 · cited 201× · PMID 31824934 · DOI 10.3389/fbioe.2019.00337

Verify or expand the search:

Other University of Mississippi Medical Center trials

Trials by the same sponsor.

NCT07431619 — A Web-Based Text Messaging for Tobacco Cessation in Rural Mississippi · NA · not yet recruiting
NCT07461662 — Evaluation of Endobronchial Ultrasound Needle Cleaning Techniques and Their Impact on Specimen Contamination · NA · not yet recruiting
NCT06216925 — Teen Mom Study: A Confirmatory Pragmatic Cluster RCT · NA · not yet recruiting
NCT06973642 — Evaluation of Home-based Telerehabilitation Platform to Augment Orthopedic Rehabilitation · NA · recruiting
NCT07071064 — Mississippi Community Engagement Alliance (MS CEAL): Fostering Community Solutions · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03941327 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Mississippi Medical Center
Last refreshed: 7 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03941327.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing